Research Article

HPV Vaccination Prevalence among Lebanese Female University Students: A Cross-Sectional Study

Table 1

Sociodemographic, behavioral, and sexual characteristics and medical history of study participants (n = 454).

Variablen (%)Mean ± SDMinMax

Sociodemographic characteristics
Age (years)22.7 ± 3.331730
NationalityLebanese432 (95.2)
Others122 (4.8)
MajorMedical2219 (48.2)
Nonmedical235 (51.8)
UniversityPublic179 (39.4)
Private275 (60.6)
Family statusMarried39 (8.6)
Single278 (61.3)
In a relationship/engaged137 (30.2)
ResidenceBeirut95 (20.9)
Mount Lebanon277 (61)
Others382 (18.1)
ReligionChristian287 (63.2)
Muslim/Druze179 (27.7)
Nonreligious18 (4)
Maternal educational levelLess than university degree203 (44.7)
University degree or higher251 (55.3)
Paternal educational levelLess than university degree266 (58.6)
University degree or higher188 (41.4)

Medical history
Personal history of cancerYes46 (1.3)
No448 (98.7)
Family history of cancer related to HPV5Yes7 (1.5)
No history447 (98.5)
History of sexually transmitted diseaseAt least once26 (5.7)
Never428 (94.3)

Behavioral characteristics
Alcohol consumptionNo167 (3)
Frequently88 (19.4)
Occasionally199 (43.8)
SmokingYes96 (21.1)
No358 (78.9)

Sexual characteristics
Age on first sexual intercourse (years)21.08 ± 4.021430
Condom useAlways38 (8.4)
Frequently35 (7.7)
Never46 (10.1)
Not currently sexually active335 (73.8)
Number of partners in generalOne140 (30.8)
Two or more15 (3.3)
Not sexually active299 (65.9)
Partner(s) genderMan145 (31.9)
Woman6 (1.3)
Both4 (0.9)
No sexual partner299 (65.9)
Sexual preference (multiple choice question)Anal giving or receptor7 (1.5)
Oral giving or receptor73 (16.1)
Vaginal sex140 (30.8)
Not sexually active299 (65.9)

SD: standard deviation. LBP: Lebanese pound. 1Other nationalities include Palestinian (n = 9), Syrian (n = 8), Iraqi (n = 3), Filipino (n = 1), and Brazilian (n = 1). 2“Medical students” include students of medicine, nursing, and pharmacy. 3Aakar, North, Baalbeck-Hermel, Beqaa, South, and Nabatiyeh. 4Breast cancer; CML, non-Hodgkin lymphoma; hodgkin lymphoma (x2); and kidney cancer. 5Cervical cancer; penile cancer; anal cancer; and oropharyngeal cancer.